Introducing the Next Generation of Peripheral Atherectomy Technology
“The acquisition of Auryon brings a remarkable, foundational technology to our portfolio that will change the way caregivers deliver treatment to patients with PAD.”
– Jim Clemmer, AngioDynamics President and Chief Executive Officer
With the Auryon system, you can offer the first peripheral atherectomy technology that efficiently and repeatedly treats any lesion type, any lesion length, at any lesion location.1
Targeted biological reactions address the risk of perforation and vaporize lesions without thermal ablation.2
A longer wavelength and shorter pulse enable world-record-breaking delivery of short UV laser pulses.3,4
Solid state delivery offers stability, no toxic gases, no calibration burden on staff, and minimal warm-up time.5
References: 1. Rundback J, Chandra P, Brodmann M, et al. Novel laser-based catheter for peripheral atherectomy: 6-month results from the Eximo Medical B-Laser™ IDE study. Catheter Cardiovasc Interv. 2019;94(7):1010-1017. 2. Herzog A, Steinberg I, Gaisenberg E, Nomberg R, Ishaaya AA. A route to laser angioplasty in the presence of fluoroscopy contrast media, using a nanosecond-pulsed 355-nm laser. IEEE J Sel Top Quantum Electron. 2016;22(3):342-347. 3. Herzog A, Steinberg I, Ishaaya AA. Shaping photomechanical effects in tissue ablation using 355 nm laser pulses. J Biophotonics. 2017;10(10):1262-1270. 4. Herzog A, Malka D, Zalevsky Z, Ishaaya AA. Effect of spatial coherence on damage occurrence in multimode optical fibers. Optics Letters. 2015;40(3):415. doi:10.1364/ol.40.000415. 5. Herzog A, Oszkinis G, Planer D, et al. Atherectomy using a solid-state laser at 355 nm wavelength. J Biophotonics. 2017;10(10):1271-1278.
For more information on Auryon, click here.